Indian medical device company developing non-invasive diagnostic technology for early detection of traumatic brain injury. Its flagship product, CEREBO, is a handheld device using near-infrared spectroscopy and machine learning to screen for intracranial bleeding at the point of care. The device holds CDSCO and DCGI clearance and was validated in collaboration with ICMR, AIIMS Bhopal and NIMHANS Bengaluru.
1StartupFox story
2013Founded
Medtech(Medical Devices)Sector
Jul 2026Latest coverage
Funding
Bioscan Research has raised $1M across 2 disclosed rounds, most recently a Seed in 22 Jul 2026.
$1MRaised
SeedLatest round · 22 Jul 2026
2Events
Chart appears once 1 more funding round is recorded — below that a chart shows less than the table does.
22 Jul 2026Seed$1MUnicorn India Ventures (lead)StartupFox ↗
Indian medical device company developing non-invasive diagnostic technology for early detection of traumatic brain injury. Its flagship product, CEREBO, is a handheld device using near-infrared spectroscopy and machine learning to screen for intracranial bleeding at the point of care. The device holds CDSCO and DCGI clearance and was validated in collaboration with ICMR, AIIMS Bhopal and NIMHANS Bengaluru.
Who founded Bioscan Research?
Bioscan Research is associated with Anupam Lavania, Shilpa Malik.
How much funding has Bioscan Research raised?
Bioscan Research has raised $1M across 2 disclosed rounds. The most recent was a $1M Seed in 22 Jul 2026.
Who are Bioscan Research's investors?
Disclosed investors in Bioscan Research include Unicorn India Ventures (lead), IIT Kanpur, iCreate, Bind 4.0; PitchBook additionally lists BIRAC, Capria Ventures, Zone Startups India.
What is the latest news on Bioscan Research?
The most recent StartupFox coverage is “Bioscan Research Raises $1 Million Seed Led by Unicorn India Ventures for CEREBO Brain Injury Device” (23 July 2026). All stories are listed on this page.